Terray Therapeutics
CA - MonroviaBiotechnology
Focus: Terray Therapeutics is a pre-revenue biotech company developing a spatially encoded screening and optimization platform technology to accelerate drug discovery and development. The company operates at an early stage focused on ophthalmology and immunology applications.
Profile data last refreshed 6h ago · AI intelligence enriched Yesterday
Open Jobs
5+2 this month
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Should You Work at Terray Therapeutics?
AI assessmentBest suited for early-stage platform scientists and manufacturing technicians willing to build from scratch; high risk, high upside if platform validates.
Why Work Here
- Platform-stage company with proprietary screening technology offering opportunity to build foundational IP and publications in early-stage drug discovery
- Active hiring across preclinical development and manufacturing signals near-term execution on platform validation and scale-up
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Terray Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.